Polydeoxyribonucleotide (PDRN) Selectively Promotes Osteoblast Differentiation Without Affecting Osteoclastogenesis

Developing novel anabolic agents for bone regeneration remains a clinical priority. Polydeoxyribonucleotide (PDRN) exhibits tissue-regenerative properties, but its direct cellular effects on bone remodeling remain unclear. This in vitro study investigated PDRN’s effects on osteoblast (MC3T3-E1) and...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Younghoon Jeon, Eunjung Heo, Xian Jin, Dong-Kyo Lee, Xiangguo Che, Hyun-Ju Kim, Sung-Hye Byun, Je-Yong Choi, Jeongkyu Choi, Jinyoung Oh
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2026-03-01
Reeks:	Marine Drugs
Onderwerpen:	polydeoxyribonucleotide osteoblast differentiation adenosine A<sub>2A</sub> receptor bone regeneration osteoclast
Online toegang:	https://www.mdpi.com/1660-3397/24/3/100
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!